nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000197	0.000197	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000197	0.000197	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000196	0.000196	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000196	0.000196	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—CREBBP—salivary gland cancer	0.000196	0.000196	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000196	0.000196	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000195	0.000195	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000195	0.000195	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CREBBP—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—PIK3CA—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000193	0.000193	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000193	0.000193	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000193	0.000193	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TP53—salivary gland cancer	0.000191	0.000191	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—salivary gland cancer	0.000187	0.000187	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000187	0.000187	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NOTCH1—salivary gland cancer	0.000186	0.000186	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000184	0.000184	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—HRAS—salivary gland cancer	0.000183	0.000183	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000182	0.000182	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000181	0.000181	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NOTCH1—salivary gland cancer	0.000181	0.000181	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—HRAS—salivary gland cancer	0.00018	0.00018	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—HRAS—salivary gland cancer	0.000179	0.000179	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000179	0.000179	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000178	0.000178	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000178	0.000178	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000176	0.000176	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CREBBP—salivary gland cancer	0.000175	0.000175	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000175	0.000175	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000173	0.000173	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—CREBBP—salivary gland cancer	0.000173	0.000173	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000172	0.000172	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—HRAS—salivary gland cancer	0.00017	0.00017	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CREBBP—salivary gland cancer	0.000169	0.000169	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CCND1—salivary gland cancer	0.000169	0.000169	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CREBBP—salivary gland cancer	0.000168	0.000168	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000166	0.000166	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000165	0.000165	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—HRAS—salivary gland cancer	0.000165	0.000165	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000165	0.000165	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOTCH1—salivary gland cancer	0.000164	0.000164	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CREBBP—salivary gland cancer	0.000164	0.000164	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PTEN—salivary gland cancer	0.000163	0.000163	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—HRAS—salivary gland cancer	0.000163	0.000163	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000161	0.000161	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CREBBP—salivary gland cancer	0.000161	0.000161	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000161	0.000161	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOTCH1—salivary gland cancer	0.00016	0.00016	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOTCH1—salivary gland cancer	0.00016	0.00016	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCND1—salivary gland cancer	0.00016	0.00016	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CREBBP—salivary gland cancer	0.000159	0.000159	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000159	0.000159	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOTCH1—salivary gland cancer	0.000158	0.000158	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000158	0.000158	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000158	0.000158	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000157	0.000157	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EP300—salivary gland cancer	0.000156	0.000156	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCND1—salivary gland cancer	0.000154	0.000154	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PTEN—salivary gland cancer	0.000154	0.000154	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000154	0.000154	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—HRAS—salivary gland cancer	0.000153	0.000153	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCND1—salivary gland cancer	0.000153	0.000153	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000151	0.000151	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—PIK3CA—salivary gland cancer	0.00015	0.00015	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000149	0.000149	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PTEN—salivary gland cancer	0.000149	0.000149	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CREBBP—salivary gland cancer	0.000149	0.000149	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PTEN—salivary gland cancer	0.000147	0.000147	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EP300—salivary gland cancer	0.000147	0.000147	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000147	0.000147	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CREBBP—salivary gland cancer	0.000146	0.000146	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CREBBP—salivary gland cancer	0.000146	0.000146	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CREBBP—salivary gland cancer	0.000145	0.000145	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—salivary gland cancer	0.000145	0.000145	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CREBBP—salivary gland cancer	0.000145	0.000145	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000144	0.000144	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCND1—salivary gland cancer	0.000144	0.000144	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000144	0.000144	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CREBBP—salivary gland cancer	0.000144	0.000144	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CREBBP—salivary gland cancer	0.000143	0.000143	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EP300—salivary gland cancer	0.000142	0.000142	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000141	0.000141	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EP300—salivary gland cancer	0.000141	0.000141	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PTEN—salivary gland cancer	0.00014	0.00014	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00014	0.00014	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00014	0.00014	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—HRAS—salivary gland cancer	0.000139	0.000139	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PTEN—salivary gland cancer	0.000139	0.000139	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—HRAS—salivary gland cancer	0.000138	0.000138	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000137	0.000137	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000137	0.000137	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000137	0.000137	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000137	0.000137	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000136	0.000136	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000135	0.000135	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000134	0.000134	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000134	0.000134	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—HRAS—salivary gland cancer	0.000133	0.000133	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—EP300—salivary gland cancer	0.000133	0.000133	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CREBBP—salivary gland cancer	0.000133	0.000133	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—HRAS—salivary gland cancer	0.000133	0.000133	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EP300—salivary gland cancer	0.000132	0.000132	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCND1—salivary gland cancer	0.00013	0.00013	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—HRAS—salivary gland cancer	0.000129	0.000129	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000127	0.000127	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—HRAS—salivary gland cancer	0.000127	0.000127	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000127	0.000127	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCND1—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PTEN—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCND1—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000124	0.000124	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000124	0.000124	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTEN—salivary gland cancer	0.000124	0.000124	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000124	0.000124	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000122	0.000122	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000122	0.000122	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCND1—salivary gland cancer	0.000121	0.000121	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PTEN—salivary gland cancer	0.000121	0.000121	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PTEN—salivary gland cancer	0.00012	0.00012	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EP300—salivary gland cancer	0.000119	0.000119	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCND1—salivary gland cancer	0.000119	0.000119	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—EP300—salivary gland cancer	0.000118	0.000118	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HRAS—salivary gland cancer	0.000117	0.000117	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PTEN—salivary gland cancer	0.000117	0.000117	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000116	0.000116	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—HRAS—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EP300—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PIK3CA—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HRAS—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PTEN—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HRAS—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EP300—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HRAS—salivary gland cancer	0.000114	0.000114	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTEN—salivary gland cancer	0.000114	0.000114	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000113	0.000113	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HRAS—salivary gland cancer	0.000113	0.000113	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HRAS—salivary gland cancer	0.000113	0.000113	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CREBBP—salivary gland cancer	0.000113	0.000113	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EP300—salivary gland cancer	0.000111	0.000111	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—salivary gland cancer	0.000111	0.000111	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CREBBP—salivary gland cancer	0.00011	0.00011	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCND1—salivary gland cancer	0.00011	0.00011	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EP300—salivary gland cancer	0.00011	0.00011	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PIK3CA—salivary gland cancer	0.000109	0.000109	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—EP300—salivary gland cancer	0.000108	0.000108	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—salivary gland cancer	0.000108	0.000108	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—salivary gland cancer	0.000108	0.000108	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—salivary gland cancer	0.000108	0.000108	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—salivary gland cancer	0.000107	0.000107	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—salivary gland cancer	0.000107	0.000107	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—salivary gland cancer	0.000106	0.000106	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTEN—salivary gland cancer	0.000106	0.000106	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—salivary gland cancer	0.000106	0.000106	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000105	0.000105	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—salivary gland cancer	0.000105	0.000105	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—salivary gland cancer	0.000105	0.000105	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTEN—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTEN—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTEN—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CREBBP—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTEN—salivary gland cancer	0.000103	0.000103	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CREBBP—salivary gland cancer	0.000103	0.000103	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTEN—salivary gland cancer	0.000102	0.000102	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTEN—salivary gland cancer	0.000102	0.000102	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—salivary gland cancer	0.000102	0.000102	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EP300—salivary gland cancer	0.000101	0.000101	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—salivary gland cancer	0.000101	0.000101	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—salivary gland cancer	0.0001	0.0001	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EP300—salivary gland cancer	9.95e-05	9.95e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EP300—salivary gland cancer	9.93e-05	9.93e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	9.93e-05	9.93e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EP300—salivary gland cancer	9.9e-05	9.9e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EP300—salivary gland cancer	9.87e-05	9.87e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—salivary gland cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—salivary gland cancer	9.84e-05	9.84e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—salivary gland cancer	9.78e-05	9.78e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EP300—salivary gland cancer	9.77e-05	9.77e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EP300—salivary gland cancer	9.75e-05	9.75e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—salivary gland cancer	9.72e-05	9.72e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—salivary gland cancer	9.62e-05	9.62e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—salivary gland cancer	9.5e-05	9.5e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—salivary gland cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EP300—salivary gland cancer	9.06e-05	9.06e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—salivary gland cancer	9.05e-05	9.05e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—salivary gland cancer	8.83e-05	8.83e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CREBBP—salivary gland cancer	8.78e-05	8.78e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—salivary gland cancer	8.73e-05	8.73e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—salivary gland cancer	8.54e-05	8.54e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—salivary gland cancer	8.52e-05	8.52e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—salivary gland cancer	8.48e-05	8.48e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—salivary gland cancer	8.25e-05	8.25e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—salivary gland cancer	8.25e-05	8.25e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—salivary gland cancer	8.2e-05	8.2e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—salivary gland cancer	8.17e-05	8.17e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—salivary gland cancer	8.12e-05	8.12e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—salivary gland cancer	8.05e-05	8.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—salivary gland cancer	8.01e-05	8.01e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—salivary gland cancer	7.98e-05	7.98e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—salivary gland cancer	7.89e-05	7.89e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—salivary gland cancer	7.85e-05	7.85e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—salivary gland cancer	7.85e-05	7.85e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—salivary gland cancer	7.85e-05	7.85e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—EP300—salivary gland cancer	7.67e-05	7.67e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—salivary gland cancer	7.63e-05	7.63e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—salivary gland cancer	7.51e-05	7.51e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—EP300—salivary gland cancer	7.49e-05	7.49e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—salivary gland cancer	7.48e-05	7.48e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—salivary gland cancer	7.4e-05	7.4e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—salivary gland cancer	7.36e-05	7.36e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—salivary gland cancer	7.35e-05	7.35e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—salivary gland cancer	7.34e-05	7.34e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—salivary gland cancer	7.32e-05	7.32e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—salivary gland cancer	7.3e-05	7.3e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—salivary gland cancer	7.24e-05	7.24e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—salivary gland cancer	7.23e-05	7.23e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—salivary gland cancer	7.21e-05	7.21e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—salivary gland cancer	7.12e-05	7.12e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—salivary gland cancer	7.11e-05	7.11e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—salivary gland cancer	7.09e-05	7.09e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—salivary gland cancer	7.06e-05	7.06e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—EP300—salivary gland cancer	7.06e-05	7.06e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—EP300—salivary gland cancer	7e-05	7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—salivary gland cancer	6.99e-05	6.99e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—salivary gland cancer	6.98e-05	6.98e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—salivary gland cancer	6.92e-05	6.92e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—salivary gland cancer	6.81e-05	6.81e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—salivary gland cancer	6.8e-05	6.8e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—salivary gland cancer	6.78e-05	6.78e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CREBBP—salivary gland cancer	6.77e-05	6.77e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—salivary gland cancer	6.75e-05	6.75e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—salivary gland cancer	6.7e-05	6.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—salivary gland cancer	6.69e-05	6.69e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—salivary gland cancer	6.67e-05	6.67e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—salivary gland cancer	6.48e-05	6.48e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—salivary gland cancer	6.27e-05	6.27e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—salivary gland cancer	6.2e-05	6.2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—EP300—salivary gland cancer	5.98e-05	5.98e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—salivary gland cancer	5.68e-05	5.68e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—salivary gland cancer	5.54e-05	5.54e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	5.22e-05	5.22e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	5.18e-05	5.18e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—salivary gland cancer	4.84e-05	4.84e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—EP300—salivary gland cancer	4.61e-05	4.61e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	4.42e-05	4.42e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	3.41e-05	3.41e-05	CbGpPWpGaD
